European Medical Solutions (EBR:ALEMS)
Belgium · Delayed Price · Currency is EUR 4.000
-0.200 (-4.76%)
Jul 22, 2026, 9:50 AM CET
EBR:ALEMS Market Cap
EBR:ALEMS has a market cap or net worth of €17.77 million as of July 21, 2026. Its market cap has decreased by -10.45% in one year.
Market Cap
17.77M
Enterprise Value
31.56M
Revenue
52.80M
Ranking
n/a
PE Ratio
9.66
Stock Price
€4.00
ChartMarket Cap Chart
Since May 11, 2016, EBR:ALEMS's market cap has decreased from 86.09M to 17.77M, a decrease of -79.36%. That is a compound annual growth rate of -14.33%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 20, 2026 | 17.52M | -20.38% |
| Dec 31, 2025 | 22.01M | -13.33% |
| Dec 31, 2024 | 25.39M | -27.47% |
| Dec 29, 2023 | 35.01M | -57.73% |
| Dec 30, 2022 | 82.82M | 1,588.91% |
| Dec 31, 2021 | 4.90M | 0.90% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| argenx SE | 47.56B |
| UCB SA | 45.31B |
| Financière de Tubize | 9.30B |
| Onward Medical | 170.69M |
| Hyloris Pharmaceuticals | 129.08M |
| Celyad Oncology | 10.70M |
| BioSenic | 1.31M |
| Oxurion NV | 230.60K |